Back to Results
First PageMeta Content
Securities / Finance / United States Securities and Exchange Commission / Corporate finance / SEC filings / Prospectus / Registration statement / Forward-looking statement / Piper Jaffray / Financial economics / Stock market / Investment


Intersect ENT Announces Pricing of its Initial Public Offering Menlo Park, Calif. – July 24, 2014 – Intersect ENT, Inc., a commercial drug-device company committed to improving the quality of life for patients with e
Add to Reading List

Document Date: 2014-07-24 07:55:15

Open Document

File Size: 132,83 KB

Share Result on Facebook

City

Minneapolis / Edgewood / /

Company

Intersect ENT Inc. / J.P. Morgan Securities LLC / Leerink Partners / Piper Jaffray & Co. / Broadridge Financial Solutions / /

Currency

USD / /

/

Event

M&A / IPO / /

Facility

Nicollet Mall / /

MedicalCondition

chronic sinusitis / /

Organization

U.S. Securities and Exchange Commission / U.S. Food and Drug Administration / /

/

ProvinceOrState

California / Minnesota / New York / /

SocialTag